In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Teligent Inc.

Latest From Teligent Inc.

Teligent Weighs Sales Of Non-Core Assets

US topicals, ophthalmics and injectables generics player Teligent has asked an investment bank to help it explore selling off non-core assets. The New Jersey-based firm wants funds to help capitalize on its newly built injectables facility.

Business Strategies North America

Teligent Prepares For Injectables Filings With Strengthened Team

As it prepares to start injectables filings from its facility in Buena, New Jersey, Teligent is putting in place its senior operational and quality functions. 

United States Business Strategies

People Round-Up: Endo Promotes Ciarico To Head Steriles And Generics

Endo has named a head for its sterile injectables and generics operations; Hikma has appointed an R&D head; Acino has a new leader for its Latin American business; Alvogen has appointed a general counsel; and Julphar has shaken up its senior management team.

Appointments Leadership

Teligent Targets Smaller Customers As It Seeks Sustainable Margins

Focusing more on smaller sales channels, as well as culling less lucrative lines, are two key strategies Teligent is employing as it seeks to raise profit margins to levels that will allow the US niche generics player to avoid breaching its debt covenants.


Business Strategies Sales & Earnings
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
    • Generic Drugs
    • OTC, Consumer
  • Services
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Inflammation
  • Alias(es)
  • IGI Inc.
  • IGI Laboratories Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teligent Inc.
  • Senior Management
  • Jason E Grenfell-Gardner, Pres. & CEO
    Damian Finio, CFO
    Mark Mantel, VP, Sales & Mktg.
    Eric Muse, VP, BD
  • Contact Info
  • Teligent Inc.
    Phone: (856) 697-1441
    105 Lincoln Ave.
    Buena, NJ 08310